BUFFALO, N.Y. -- According to the American Cancer Society, one in 95 women will get ovarian cancer in their lifetime. Each year, more than 22,000 women are diagnosed with it and more than 14,000 women die from the disease.
Roswell Park Cancer Institute said there is currently no test to effectively screen all women for early signs. Doctors, however, are hoping a new grant will make leaps and bounds in preventing and curing the disease.
Monday, Roswell Park was awarded a Specialized Program of Research Excellence (SPORE) grant. The grant is $11-million over five years. It will fund four projects at Roswell Park, in conjunction with the University of Pittsburgh Cancer Institute.
"This SPORE grant has implications for Western New York and beyond Western New York. It has global implications," said Principal Investigator of the SPORE grant Dr. Kunle Odunsi.
Roswell Park officials said the grant is huge for the area, but they're also thinking about the current government shutdown, and the effects it's had on research and patient care.
Roswell Park said, luckily, the government shutdown will not affect the SPORE grant but they said the longer the shutdown goes, it could begin to impact future grants.
"The real impact will be on the review of grants that have been submitted and their approval and funding will all be pushed back," said Dr. Donald Trump, President & CEO of Roswell Park Cancer Institute.
Dr. Trump said the Sequestration from early 2013 still affects grant processing, and the longer the shutdown goes, the more it will hurt.
"This will delay the process of advancement of science and research," Dr. Trump said.
Dr. Trump said, as of now, clinical trials are still going on at Roswell Park and they will be reassessing as long as the shutdown continues.